Tower Research Capital (TRC)’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $363K | Buy |
2,807
+1,267
| +82% | +$182K | 0.01% | 1163 |
|
|
2025
Q4 | $220K | Sell |
1,540
-564
| -27% | -$75.6K | 0.01% | 1372 |
|
|
2025
Q3 | $252K | Sell |
2,104
-469
| -18% | -$59.4K | 0.01% | 1301 |
|
|
2025
Q2 | $340K | Buy |
2,573
+2,091
| +434% | +$283K | 0.01% | 1316 |
|
|
2025
Q1 | $66.9K | Sell |
482
-870
| -64% | -$135K | ﹤0.01% | 2010 |
|
|
2024
Q4 | $210K | Buy |
1,352
+632
| +88% | +$107K | ﹤0.01% | 1689 |
|
|
2024
Q3 | $131K | Buy |
720
+570
| +380% | +$84.4K | ﹤0.01% | 2010 |
|
|
2024
Q2 | $17.8K | Sell |
150
-313
| -68% | -$32.9K | ﹤0.01% | 3820 |
|
|
2024
Q1 | $49.7K | Sell |
463
-917
| -66% | -$91.2K | ﹤0.01% | 2279 |
|
|
2023
Q4 | $138K | Sell |
1,380
-656
| -32% | -$64.1K | ﹤0.01% | 2385 |
|
|
2023
Q3 | $242K | Sell |
2,036
-1,483
| -42% | -$221K | 0.01% | 1314 |
|
|
2023
Q2 | $627K | Buy |
3,519
+2,174
| +162% | +$399K | 0.02% | 828 |
|
|
2023
Q1 | $222K | Buy |
1,345
+934
| +227% | +$161K | 0.01% | 1310 |
|
|
2022
Q4 | $65K | Sell |
411
-1,323
| -76% | -$201K | ﹤0.01% | 2150 |
|
|
2022
Q3 | $261K | Sell |
1,734
-6,111
| -78% | -$1.02M | ﹤0.01% | 1666 |
|
|
2022
Q2 | $1.29M | Buy |
7,845
+3,366
| +75% | +$648K | 0.03% | 558 |
|
|
2022
Q1 | $997K | Buy |
4,479
+2,509
| +127% | +$562K | 0.01% | 789 |
|
|
2021
Q4 | $467K | Buy |
1,970
+616
| +45% | +$144K | 0.01% | 1162 |
|
|
2021
Q3 | $316K | Buy |
1,354
+76
| +6% | +$15.9K | 0.01% | 1351 |
|
|
2021
Q2 | $263K | Buy |
1,278
+264
| +26% | +$54.3K | 0.01% | 1711 |
|
|
2021
Q1 | $208K | Sell |
1,014
-4,396
| -81% | -$928K | ﹤0.01% | 1978 |
|
|
2020
Q4 | $1.16M | Sell |
5,410
-1,587
| -23% | -$308K | 0.04% | 442 |
|
|
2020
Q3 | $1.28M | Buy |
6,997
+1,724
| +33% | +$325K | 0.01% | 743 |
|
|
2020
Q2 | $972K | Buy |
5,273
+5,053
| +2,297% | +$1M | 0.04% | 541 |
|
|
2020
Q1 | $44K | Sell |
220
-837
| -79% | -$161K | ﹤0.01% | 1350 |
|
|
2019
Q4 | $198K | Buy |
1,057
+971
| +1,129% | +$167K | 0.02% | 591 |
|
|
2019
Q3 | $14K | Sell |
86
-172
| -67% | -$34.2K | ﹤0.01% | 2728 |
|
|
2019
Q2 | $65K | Sell |
258
-374
| -59% | -$86.7K | ﹤0.01% | 1427 |
|
|
2019
Q1 | $152K | Buy |
632
+463
| +274% | +$111K | 0.01% | 1242 |
|
|
2018
Q4 | $39K | Sell |
169
-1,410
| -89% | -$348K | ﹤0.01% | 1453 |
|
|
2018
Q3 | $447K | Buy |
1,579
+1,409
| +829% | +$413K | 0.03% | 538 |
|
|
2018
Q2 | $50K | Sell |
170
-342
| -67% | -$93.5K | ﹤0.01% | 1849 |
|
|
2018
Q1 | $129K | Buy |
+512
| New | +$120K | 0.01% | 1108 |
|
|
2017
Q4 | – | Sell |
-2,010
| Closed | -$374K | – | 3735 |
|
|
2017
Q3 | $374K | Buy |
+2,010
| New | +$351K | 0.03% | 371 |
|
|
2017
Q2 | – | Sell |
-86
| Closed | -$13K | – | 3037 |
|
|
2017
Q1 | $13K | Sell |
86
-75
| -47% | -$11K | ﹤0.01% | 1589 |
|
|
2016
Q4 | $24K | Buy |
+161
| New | +$23.3K | ﹤0.01% | 1972 |
|
|
2016
Q3 | – | Sell |
-1,102
| Closed | -$124K | – | 3995 |
|
|
2016
Q2 | $124K | Buy |
+1,102
| New | +$114K | 0.01% | 970 |
|
|
2015
Q2 | – | Sell |
-410
| Closed | -$38K | – | 4667 |
|
|
2015
Q1 | $38K | Buy |
410
+401
| +4,456% | +$35.1K | ﹤0.01% | 1697 |
|
|
2014
Q4 | $1K | Sell |
9
-1,682
| -99% | -$129K | ﹤0.01% | 3651 |
|
|
2014
Q3 | $109K | Buy |
1,691
+1,518
| +877% | +$93K | 0.01% | 855 |
|
|
2014
Q2 | $11K | Sell |
173
-125
| -42% | -$7.38K | ﹤0.01% | 2280 |
|
|
2014
Q1 | $18K | Buy |
+298
| New | +$18.4K | ﹤0.01% | 1996 |
|
|
2013
Q4 | – | Sell |
-1,394
| Closed | -$94K | – | 4678 |
|
|
2013
Q3 | $94K | Buy |
1,394
+1,018
| +271% | +$72.7K | 0.01% | 1352 |
|
|
2013
Q2 | $27K | Buy |
+376
| New | +$24.9K | ﹤0.01% | 1435 |
|
Other funds holding ICUI
VPM
VCM
RRAM
Tower Research Capital (TRC)'s ICUI Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its ICU Medical (ICUI) stake by 82% in Q1 2026, buying an estimated $182K and bringing the position to 2,807 shares worth $363K. The position accounts for 0.01% of the portfolio, ranked #1163.
Tower Research Capital (TRC) first reported a position in ICUI in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.29M in Q2 2022. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- Tower Research Capital (TRC) held 2,807 shares of ICU Medical worth $363K as of Q1 2026.
- Tower Research Capital (TRC) bought 1,267 ICU Medical shares in Q1 2026, an estimated $182K.
- ICU Medical made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1163 holding.
- Tower Research Capital (TRC) first reported a position in ICU Medical in Q2 2013 and has held it in 44 quarters since.
- Tower Research Capital (TRC)'s ICU Medical position peaked at $1.29M in Q2 2022.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.